Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1998-11-24
pubmed:abstractText
Advanced HIV disease is associated with a high prevalence of cervical squamous intra-epithelial lesions (SIL) and of infection with oncogenic human papillomavirus (HPV) genotypes. Triple-combination antiretroviral therapy results in decreased plasma HIV viral load, increased CD4 cell counts and partial restoration of immune functions in patients with severe HIV disease. This study investigated the outcome of SIL in HIV-seropositive women undergoing triple combination antiretroviral treatment.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0269-9370
pubmed:author
pubmed:issnType
Print
pubmed:day
20
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1459-64
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9727566-Adult, pubmed-meshheading:9727566-Anti-HIV Agents, pubmed-meshheading:9727566-Blotting, Southern, pubmed-meshheading:9727566-CD4 Lymphocyte Count, pubmed-meshheading:9727566-Carcinoma, Squamous Cell, pubmed-meshheading:9727566-Cervical Intraepithelial Neoplasia, pubmed-meshheading:9727566-DNA, Viral, pubmed-meshheading:9727566-Female, pubmed-meshheading:9727566-HIV, pubmed-meshheading:9727566-HIV Seropositivity, pubmed-meshheading:9727566-Humans, pubmed-meshheading:9727566-Middle Aged, pubmed-meshheading:9727566-Papillomaviridae, pubmed-meshheading:9727566-Papillomavirus Infections, pubmed-meshheading:9727566-Polymerase Chain Reaction, pubmed-meshheading:9727566-Prospective Studies, pubmed-meshheading:9727566-RNA, Viral, pubmed-meshheading:9727566-Treatment Outcome, pubmed-meshheading:9727566-Uterine Cervical Neoplasms, pubmed-meshheading:9727566-Vaginal Smears, pubmed-meshheading:9727566-Viral Load
pubmed:year
1998
pubmed:articleTitle
Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy.
pubmed:affiliation
INSERM U 430 and Université Pierre et Marie Curie, Hôpital Broussais, Paris, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't